New methods for activation of kinases and kinase circuits in living cells.
New methods for activation of kinases and kinase circuits in living cells.
批准号:
8469837
负责人:
ANDREI V KARGINOV
金额:
$16.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2015-06-30
关键词:
AffectBindingBiologicalBiological ModelsBiological ProcessCCI-779CalcineurinCatalytic DomainCell Surface ExtensionsCellsDependenceDevelopmentDimerizationDiseaseDoseEngineeringEventFK506Family memberFocal Adhesion Kinase 1Focal AdhesionsHeterodimerizationHumanKineticsLeadLifeLightLocationMAPK14 geneMediatingMembraneMethodsOrganOutcomePathway interactionsPhenotypePhosphotransferasesPositioning AttributeProtein EngineeringProtein KinaseReagentRegulationResolutionRoleScientistSignal PathwaySirolimusSpecificitySystemTacrolimus Binding ProteinsTechniquesTechnologyTestingTimeWorkanalogbasecell behaviorcell motilityinhibitor/antagonistmetaplastic cell transformationmutantnovel strategiesprotein complexsrc-Family Kinasestool
中文摘要
描述(由申请人提供):仍然难以在活细胞中精确定时和定位地操纵蛋白激酶活性。此外,目前大多数生物学研究不可能仅在选定的蛋白质复合物中靶向操纵激酶活性。我们最近开发了一种新的普遍适用的方法雷帕霉素调节(RapR)激活激酶,并成功地将其应用于三种激酶从两个不同的类,酪氨酸和丝氨酸/苏氨酸激酶(FAK,Src和p38)。在这里,我们建议采用RapR技术开发新的广泛适用的方法,用于选择性调节活细胞中高度同源的激酶,并仅当它们处于特定的蛋白质复合物中时才靶向激活激酶。我们还将利用笼状雷帕霉素实现光介导的激酶局部调节。这些方法将被应用于确定不同的Src家族激酶的作用。这些高度同源的激酶是对新方法特异性的一个很好的测试,并将提供新的能力来回答以前难以解决的问题。局部激活将用于探测调节细胞突起和极化的途径的时空调节。
英文摘要
DESCRIPTION (provided by applicant): It remains difficult to manipulate protein kinase activity with precise timing and localization in living cells. Furthermore, targeted manipulation of kinase activity only in selected protein complexes is currently impossible for the majority of biological studies. We have recently developed a new generally applicable method for rapamycin-regulated (RapR) activation of kinases and successfully applied it to three kinases from two different classes, tyr and ser/thr kinases (FAK, Src, and p38). Here, we propose to employ RapR technology to develop new broadly applicable methods for selective regulation of highly homologous kinases in living cells, and targeted activation of kinases only when they are in specific protein complexes. We will also achieve light- mediated localized regulation of kinases using caged rapamycin. These methods will be applied to identify the roles of different Src family kinases. These highly homologous kinases serve as a good test of the specificity of the new approaches and will provide new capabilities to answer previously intractable questions. Localized activation will be used to probe the spatio-temporal regulation of pathways modulating cell protrusion and polarization.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Dissecting Kinase Effector Signaling Using the RapRTAP Methodology.
使用 RapRTAP 方法剖析激酶效应器信号传导。
DOI:
10.1007/978-1-4939-7154-1_2
发表时间:
2017
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Ray,Anne-Marie, Klomp,JenniferE, Collins,KerrieB, Karginov,AndreiV]
通讯作者:
Karginov,AndreiV
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
-
批准号:10640927
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Regulation of endothelial cell invasion, migration and cell junction plasticity
-
批准号:10406685
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
-
批准号:10413468
-
项目类别:
-
资助金额:$40.36万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Regulation of endothelial cell invasion, migration and cell junction plasticity
-
批准号:10685981
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2022
-
负责人:ANDREI V KARGINOV
-
依托单位:
Synthetic Biology and Optogenetics Core
-
批准号:10701925
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2021
-
负责人:ANDREI V KARGINOV
-
依托单位:
Synthetic Biology and Optogenetics Core
-
批准号:10170860
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2021
-
负责人:ANDREI V KARGINOV
-
依托单位:
Synthetic Biology and Optogenetics Core
-
批准号:10491052
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2021
-
负责人:ANDREI V KARGINOV
-
依托单位:
Optogenetic tools for the dissection of oncogenic signaling mediated by kinases
-
批准号:9891973
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2018
-
负责人:ANDREI V KARGINOV
-
依托单位:
Src-mediated pathways regulating adherens junction assembly.
-
批准号:10166863
-
项目类别:
-
资助金额:$31.38万
-
财政年份:2017
-
负责人:ANDREI V KARGINOV
-
依托单位:
Src-mediated pathways regulating adherens junction assembly.
-
批准号:9310733
-
项目类别:
-
资助金额:$31.38万
-
财政年份:2017
-
负责人:ANDREI V KARGINOV
-
依托单位:
New methods for activation of kinases and kinase circuits in living cells.
-
批准号:8243734
-
项目类别:
-
资助金额:$20.81万
-
财政年份:2012
-
负责人:ANDREI V KARGINOV
-
依托单位:
Macromolecular Engineering
-
批准号:9151428
-
项目类别:
-
资助金额:$28.46万
-
财政年份:--
-
负责人:ANDREI V KARGINOV
-
依托单位:
Macromolecular Engineering
-
批准号:9324307
-
项目类别:
-
资助金额:$28.46万
-
财政年份:--
-
负责人:ANDREI V KARGINOV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: